DBDiane R. Blake

Diane R. Blake

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Diane R. Blake has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Celeste A. Lemay

    University of Massachusetts Medical School, Worcester, MA, USA

    4 shared publications
  • Thomas C. Quinn

    3 shared publications
  • Charlotte A. Gaydos

    2 shared publications
  • Alka Indurkhya

    1 shared publication
  • Amy B. Middleman

    Department of Pediatrics, University of Oklahoma Health Sciences Center, 1200 Children's Avenue, Suite 12200, Oklahoma City, OK 73104, USA

    1 shared publication
  • Andrew Bs Hardick

    From the *Department of Pediatrics, Division of Adolescent Medicine; University of Massachusetts Medical School, Worcester, Massachusetts; †Department of Medicine, Division of Infectious Diseases; Johns Hopkins University School of Medicine, Baltimore, Maryland; and ‡National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland

    1 shared publication

Latest Publications

  • Human Papillomavirus Vaccine Update

    by Diane R. Blake, Amy B. Middleman


  • Power of Knowledge

    by Rachel S. Sagor, Jeremy Golding, Margaret M. Giorgio, Diane R. Blake

    We compared (a) the effectiveness of print versus digital educational media for communicating information about Chlamydia trachomatis to adolescents and young adults and (b) the influence of media type on readiness for Chlamydia screening. Young men and women (n = 103), aged 15 to 24 years, were recruited from a youth center and university campus and randomized to receive the print or digital Chlamydia educational intervention. Participant mean knowledge score improved postintervention, but there was no association with type of intervention medium. Nearly two-thirds (61%) of sexually active participants endorsed an increased postintervention stage of readiness for screening; however, there was no association with type of intervention medium. Learning about Chlamydia infection may have positive effects on willingness to be screened. Further study is needed to evaluate the efficacy of educational interventions for increasing actual screening rates.


  • Development and evaluation of a web-based assent for adolescents considering an HIV vaccine trial

    by Diane R. Blake, Celeste A. Lemay, Louise S. Maranda, J. Dennis Fortenberry, Margaret H. Kearney, Kathleen M. Mazor

    HIV vaccine trials with minors will likely require parental permission and informed assent from adolescents. For this to be a valid process, the information needs to be presented in a manner that promotes adolescent comprehension. Previous studies suggest that adolescent comprehension of assent is often insufficient. We developed an interactive web-based assent that included interspersed quiz questions for a hypothetical HIV vaccine trial. Efficacy of the web-based assent was compared to a standard paper assent with and without interspersed questions. One hundred twenty teen participants, ages 15–17 years, from five community organizations were randomized to self-administered web-based assent (n = 60) or investigator-administered paper assent with (n = 29) or without (n = 31) interspersed quiz questions. After reviewing the assent, participants completed a 27-item comprehension test. Comprehension scores were compared between groups. The mean number of correctly answered questions were 21.2 for the full paper group and 21.1 for the web-based group (t118 = –0.08, p = 0.94). Scores were 20.2 for the paper without interspersed questions sub-group and 22.1 for the paper with interspersed questions sub-group (t58 = 1.96, p = 0.055). Participants in the web-based group performed as well on the comprehension test as those in the paper group, and those in the paper with questions sub-group performed better than those in the paper without questions sub-group, suggesting that interspersed quiz questions may improve understanding of a traditional paper assent. The minimal investigator time and standardized administration of the web-based assent as well as ability to tailor the assent discussion to topics identified by incorrect comprehension test responses are advantages worthy of further investigation.


  • Could Home Sexually Transmitted Infection Specimen Collection With e-Prescription Be a Cost-Effective Strategy for Clinical Trials and Clinical Care?

    by Diane R. Blake, Freya Spielberg, Vivian Levy, Shelly Lensing, Peter A. Mha Wolff, Lalitha Bs Venkatasubramanian, Nincoshka Bs Acevedo, Nancy Padian, Ishita Mph Chattopadhyay, Charlotte A. DrPH Gaydos

    Background Results of a recent demonstration project evaluating feasibility, acceptability, and cost of a Web-based sexually transmitted infection (STI) testing and e-prescription treatment program (eSTI) suggest that this approach could be a feasible alternative to clinic-based testing and treatment, but the results need to be confirmed by a randomized comparative effectiveness trial. Methods We modeled a decision tree comparing (1) cost of eSTI screening using a home collection kit and an e-prescription for uncomplicated treatment versus (2) hypothetical costs derived from the literature for referral to standard clinic-based STI screening and treatment. Primary outcome was number of STIs detected. Analyses were conducted from the clinical trial perspective and the health care system perspective. Results The eSTI strategy detected 75 infections, and the clinic referral strategy detected 45 infections. Total cost of eSTI was $94,938 ($1266/STI detected) from the clinical trial perspective and $96,088 ($1281/STI detected) from the health care system perspective. Total cost of clinic referral was $87,367 ($1941/STI detected) from the clinical trial perspective and $71,668 ($1593/STI detected) from the health care system perspective. Conclusions Results indicate that eSTI will likely be more cost-effective (lower cost/STI detected) than clinic-based STI screening, both in the context of clinical trials and in routine clinical care. Although our results are promising, they are based on a demonstration project and estimates from other small studies. A comparative effectiveness research trial is needed to determine actual cost and impact of the eSTI system on identification and treatment of new infections and prevention of their sequelae.


  • Adolescent and Young Adult Understanding of the Differences Between Chlamydia, HIV, and AIDS

    by James G. Anderson, Celeste A. Lemay, Louise Maranda, Diane R. Blake

    Objective. To explore young people’s understanding of the differences between Chlamydia, HIV, and AIDS. Methods. Participants from a hospital-based adolescent clinic completed a self-administered written survey. Three questions assessed participants’ understanding of the differences between Chlamydia, HIV, and AIDS. Results. Nearly half of the 119 participants selected “No” or “Don’t know” when asked if there are differences between Chlamydia and HIV and between HIV and AIDS. Increasing age was associated with correct response. Conclusions. A large proportion of youth in this sample did not know that there are differences between Chlamydia, HIV, and AIDS. Previous research suggests that some young people are afraid to be screened for Chlamydia because they fear that a Chlamydia diagnosis has the same ramifications as an AIDS diagnosis. Findings from this study indicate that more education about the differences between Chlamydia, HIV, and AIDS is needed.


  • Open Access

    Adolescents' Understanding of Research Concepts

    by Diane R. Blake, Celeste A. Lemay, Margaret H. Kearney, Kathleen M. Mazor

    ObjectiveTo identify ways to improve adolescents' understanding of informed assent by exploring adolescent comprehension of concepts common to all clinical trials as well as those specific to a human immunodeficiency virus vaccine trial.DesignQualitative descriptive study.SettingCommunity-based organizations.ParticipantsHealthy adolescents aged 15 to 17 years in 8 focus groups.InterventionFocus groups were conducted using a semistructured interview guide. Digital recordings of the groups were transcribed verbatim.Outcome MeasureTextual data were categorized by 2 investigators using directed qualitative content analysis techniques. Major themes and subthemes were identified, and representative quotes were selected.ResultsThe general research concepts that were most difficult for teens to understand were placebo and randomization. The most difficult vaccine trial concepts were how a vaccine works and that a vaccine is used for prevention rather than treatment. The most difficult human immunodeficiency virus vaccine–specific trial concept was that standard human immunodeficiency virus antibody tests might provide a false-positive result for participants receiving the test vaccine. Focus group participants wanted to be informed about adverse effects, trial procedures, and whether previous research had been performed before making a decision about trial participation.ConclusionsMany clinical trial concepts were difficult for teens to understand. Attention needs to be directed toward developing effective ways to explain these concepts to adolescents participating in future human immunodeficiency virus vaccine and other clinical trials.


  • Cost-Effectiveness of Screening Strategies for Chlamydia trachomatis Using Cervical Swabs, Urine, and Self-Obtained Vaginal Swabs in a Sexually Transmitted Disease Clinic Setting

    by Diane R. Blake, Nancy Maldeis, Mathilda R. Bs Barnes, Andrew Bs Hardick, THOMAS C. MD QUINN, CHARLOTTE A. MS GAYDOS

    Background: We evaluated the cost-effectiveness of Chlamydia screening strategies that use different methods of specimen collection: cervical swabs, urines, and self-obtained vaginal swabs. Methods: A decision analysis was modeled for a hypothetical cohort of 10,000 per year of women attending sexually transmitted disease (STD) clinics. Incremental cost-effectiveness of 4 screening strategies were compared: 1) Endocervical DNA probe test (PACE2, Gen-Probe), 2) Endocervical AC2 (Aptima Combo 2, Gen-Probe), 3) Self-Obtained Vaginal AC2, and 4) Urine AC2. Sensitivities of the vaginal, urine, and cervical AC2 tests were derived from 324 women attending STD clinics. The primary outcome was cases of pelvic inflammatory disease prevented. The model incorporated programmatic screening and treatment costs and medical cost savings from sequelae prevented. Results: Chlamydia prevalence in the sampled population was 11.1%. Sensitivities of vaginal, urine, and cervical AC2 were 97.2%, 91.7%, and 91.7%, respectively. The sensitivity of the DNA probe was derived from the literature and estimated at 68.8%. The self-obtained vaginal AC2 strategy was the least expensive and the most cost-effective, preventing 17 more cases of pelvic inflammatory disease than the next least expensive strategy. Conclusions: Use of a vaginal swab to detect Chlamydia in this STD clinic population was cost-saving and cost-effective.


  • Should Asymptomatic Men Be Included in Chlamydia Screening Programs? Cost-Effectiveness of Chlamydia Screening Among Male and Female Entrants to a National Job Training Program

    by Diane R. Blake, Thomas C. Quinn, Charlotte A. Gaydos

    To compare the cost-effectiveness of various chlamydia screening strategies within a population of male and female youth entering a national job training program. Cost-effectiveness analysis of various chlamydia screening strategies among a cohort of 4000 female and male New England job training students. Strategies for women include (a) no screening, (b) universal endocervical DNA probe screening, (c) universal urine based NAAT screening, and (d) universal endocervical NAAT screening. Strategies for men include (a) no screening, (b) selective urine NAAT screening of leukocyte esterase (LE)-positive urines, and (c) universal urine-based NAAT screening. Universal endocervical NAAT screening of women and universal urine NAAT screening of men were the most effective and cost-effective strategies individually and in combination. Endocervical NAAT screening of women prevented 23 more cases of PID and saved $27,000 more than endocervical DNA probe screening. Likewise, universal urine NAAT screening of men prevented 21 more cases of PID in their female partners and saved $16,000 more than selective urine NAAT screening of LE positive men. Use of a sensitive NAAT to screen both men and women for chlamydia upon entry to a National Job Training Program is cost-effective, cost-saving, and provides a public health opportunity to substantially reduce chlamydia infections among youth at risk for sexually transmitted diseases.


  • Correlates of Readiness to Receive Chlamydia Screening Among 2 Populations of Youths

    by Diane R. Blake, Celeste A. Lemay, Alka Indurkhya

    Research from JAMA Pediatrics — Correlates of Readiness to Receive Chlamydia Screening Among 2 Populations of Youths


  • Open Access

    Patterns and Knowledge of Nonmedical Use of Stimulants Among College Students

    by Bronwen C. Carroll, Thomas J. McLaughlin, Diane R. Blake

    Objective To determine patterns and knowledge of nonmedical use of stimulants among a sample of college students. Design Completion of an anonymous survey consisting of 23 questions designed to explore college student use of medications intended to treat attention-deficit/hyperactivity disorder. Setting A private liberal arts college in New England. Participants Three hundred forty-seven undergraduate students. Main Outcome Measure Nonmedical use of stimulants. Results Thirty-one students (9.2%) reported nonmedical stimulant use. Two hundred forty students (71.4%) had peers who used nonprescribed stimulants, 149 (44.3%) knew of peers who made stimulant medication–seeking visits to a physician although they did not believe that they had attention-deficit/hyperactivity disorder, and 178 (53.0%) knew of people who sold stimulants to students. Nonprescription users were significantly more knowledgeable about the effects of stimulants than nonusers, and nonusers whose peers used nonprescribed stimulants were more knowledgeable about the effects of stimulants than nonusers whose peers did not use nonprescribed stimulants. After controlling for age, race, and sex, the variables that predicted nonmedical use of stimulants were beliefs that stimulants help individuals study better, stay awake, and lose weight. Conclusions A substantial proportion of college students in this sample were using nonprescribed stimulants. Among nonusers, those whose peers use nonprescribed stimulants were much more knowledgeable about the effects of stimulant use than those whose peers do not use stimulants. This knowledge may confer an increased risk of future nonmedical stimulant use if students become tempted to seek the beneficial effects experienced by their peers.